Noveris Health Sciences Inc. (CSE:NVRS)

Canada flag Canada · Delayed Price · Currency is CAD
0.200
0.00 (0.00%)
At close: Feb 26, 2026
-20.00%
Market Cap 247.01K
Revenue (ttm) n/a
Net Income (ttm) 2.29M
Shares Out 1.24M
EPS (ttm) 1.85
PE Ratio 0.11
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,000
Average Volume 2,196
Open 0.200
Previous Close n/a
Day's Range 0.200 - 0.200
52-Week Range 0.120 - 0.500
Beta 2.34
RSI 43.39
Earnings Date Mar 31, 2026

About Noveris Health Sciences

Noveris Health Sciences Inc., a biotechnology company, engages in the research, development, and commercialization of psilocybin products to treat mental health conditions. The company primarily focuses on treating nicotine addiction and post-traumatic stress disorder. It also develops MYCO-005, MYCO-006, and MYCO-007 for MDMA and psilocybin analogs. The company has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. Noveris Health Sciences... [Read more]

Industry Agricultural Production Crops
Founded 2013
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol NVRS
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.